›Weight based dosing per INR and institutional guideline
›Repeat INR
›Vitamin K IV
›5 to 10 mg IV
›Repeat INR monitoring
Nonoperative management pathway
›Observation based management
›Hemodynamic stability requirements
›No ongoing hypotension from hemorrhage
›No escalating transfusion requirement
›Monitoring elements
›Serial abdominal exams
›Serial hemoglobin based on stability
›Repeat imaging triggers
›New abdominal pain
›Drop in hemoglobin with instability
›Angioembolization indications
›CT active contrast extravasation
›Pseudoaneurysm
›Ongoing transfusion requirement with stable enough physiology
›Venous thromboembolism prophylaxis timing
›Mechanical prophylaxis early
›Pharmacologic prophylaxis when bleeding stabilized per trauma protocol
Operative management pathway
›Indications for laparotomy
›Hemodynamic instability with positive FAST not responsive to resuscitation
›Peritonitis suggesting hollow viscus injury
›Penetrating injury with hemodynamic instability
›Damage control surgery concepts
›Perihepatic packing
›Temporary tamponade
›Planned re exploration
›Pringle maneuver
›Temporary inflow occlusion
›Persistent bleeding suggests hepatic venous or retrohepatic source
›Adjuncts
›Topical hemostatic agents
›Temporary abdominal closure
Analgesia and supportive care
›Pain control strategy
›Opioid analgesia
›Fentanyl IV
›25 to 50 mcg IV
›Repeat every 5 to 10 minutes as needed
›Monitoring for respiratory depression
›Hydromorphone IV
›0.2 to 0.5 mg IV
›Repeat every 10 to 15 minutes as needed
›Dose reduction in elderly
›Non opioid adjuncts
›Acetaminophen
›Avoid high total daily dosing in liver disease
›Consider reduced maximum per institutional policy
›Regional anesthesia consideration
›Rib fracture pain blocks if concomitant chest trauma
›Anticoagulation status awareness
›Nausea management
›Ondansetron IV
›4 mg IV
›Repeat dosing per nausea severity
›QT prolongation risk awareness
Infection prophylaxis and antibiotics
›Penetrating abdominal trauma coverage
›Broad spectrum antibiotics for hollow viscus contamination concern
›Ceftriaxone IV
›2 g IV daily
›Add metronidazole if anaerobic coverage needed
›500 mg IV every 8 hours
›Piperacillin tazobactam IV alternative
›4.5 g IV every 6 hours
›Renal dosing adjustment
›De escalation based on findings
›Biliary complication management
›Suspected cholangitis or infected biloma
›Broad spectrum antibiotics with biliary penetration
›Source control planning with drainage